Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 133 of 200 Β· By data quality, then INN

  1. pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted)

    ADJUPANRIX (PREVIOUSLY PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED) GLAXOSMITHKLINE BIOLOGICALS)

    EMA: approved

    J07BB02
  2. pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)

    FOCLIVIA

    EMA: approved

    J07BB02
  3. pandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures)

    INCELLIPAN

    EMA: approved

    J07BB02
  4. pandemic influenza vaccine (h5n1) (whole virion, inactivated, prepared in cell culture)

    PANDEMIC INFLUENZA VACCINE H5N1 BAXTER AG

    EMA: withdrawn

    J07BB01
  5. pandemic influenza vaccine (whole virion, inactivated, adjuvanted)

    DARONRIX

    EMA: unknown

    J07BB01
  6. panobinostat

    FARYDAK

    EMA: approved

    L01XH03
  7. para-aminosalicylic acid

    GRANUPAS (PREVIOUSLY PARA-AMINOSALICYLIC ACID LUCANE)

    EMA: withdrawn

    J04AA01
  8. parathyroid hormone (rdna)

    PREOTACT

    EMA: withdrawn

    H05AA03
  9. parecoxib

    DYNASTAT

    EMA: approved

    M01AH04
  10. parsaclisib

    PARSACLISIB INCYTE BIOSCIENCES DISTRIBUTION B.V.

    EMA: application withdrawn

    L01EM04
  11. pasireotide

    SIGNIFOR

    EMA: approved

    H01CB05
  12. patiromer

    VELTASSA Seqirus (Australia) Pty Ltd

    EMA: approved Β· TGA: approved

    V03AE09
  13. pazopanib

    PAZOPANIB ADVZ Novartis Pharmaceuticals

    EMA: approved Β· TGA: approved

    L01XE11
  14. pegaptanib

    MACUGEN

    EMA: withdrawn

    S01LA03
  15. pegaspargase

    ONCASPAR

    FDA: approved Β· EMA: approved

    L01XX24
  16. pegfilgrastim

    PELGRAZ Accord Healthcare Pty.

    FDA: approved Β· EMA: approved Β· TGA: approved

    L03AA13
  17. peginterferon alfa-2b

    CYLATRON

    FDA: approved Β· EMA: withdrawn

    L03AB10
  18. pegunigalsidase alfa

    ELFABRIO

    EMA: approved

    A16AB20
  19. pegzilarginase

    LOARGYS

    EMA: approved

    A16AB24
  20. perflubutane

    IMAGIFY

    EMA: application withdrawn

    V08D
  21. pertussis vaccine (recombinant, acellular, component, adsorbed)

    VACPERTAGEN

    EMA: approved

    J07AJ02
  22. pexidartinib

    TURALIO

    EMA: refused

    L01XE
  23. phentermine

    QSIVA

    EMA: refused

  24. phenylephrine

    OMIDRIA

    EMA: approved

    S01

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.